# Miltefosine and GM-CSF in Cutaneous Leishmaniasis

> **NCT03023111** · PHASE3 · COMPLETED · sponsor: **Hospital Universitário Professor Edgard Santos** · enrollment: 300 (actual)

## Conditions studied

- Cutaneous Leishmaniasis

## Interventions

- **DRUG:** Sbv
- **DRUG:** Miltefosine plus placebo
- **DRUG:** Miltefosine plus GM-CSF

## Key facts

- **NCT ID:** NCT03023111
- **Lead sponsor:** Hospital Universitário Professor Edgard Santos
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-30
- **Primary completion:** 2019-08-09
- **Final completion:** 2020-02-14
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2020-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03023111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03023111, "Miltefosine and GM-CSF in Cutaneous Leishmaniasis". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03023111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*